Pressmeddelanden, rapporter och bolagsmeddelande för Curasight
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight announces acceleration of therapeutic strategy to strengthen position as a radiopharmaceutical theranostic company
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S Achieves First Milestone under collaboration with Curium Inc.
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S submits clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S appoints CRO to run Phase 2 study with uTRACE[®] in prostate cancer
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital and Stokk.io
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim Report January – September 2023
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight A/S reports positive preclinical results with uTREAT[®] in lung cancer (NSCLC)
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague
Spotlight News
Nyhetsuppdatering från Curasight
Press release from Companies: Curasight to present at HC Andersen Capital and at HC Andersen Life Science seminar
Spotlight News
Nyhetsuppdatering från Curasight
Reports: Interim Report January – June 2023